Skip to search formSkip to main contentSkip to account menu

Fluorofenidone

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Interleukin (IL)‐1β plays an important role in the pathogenesis of idiopathic pulmonary fibrosis. The production of IL‐1β is… 
2015
2015
Apoptosis is one of the most important mechanisms underlying renal tubulointerstitial fibrosis. We identified a role of protein… 
2015
2015
Background/Aims: We evaluated the therapeutic effects of fluorofenidone (AKF-PD), a novel pyridone agent, targeting oxidative… 
2015
2015
Signaling through the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway, especially JAK2/STAT3… 
2013
2013
Fluorofenidone (AKF‐PD) is a novel pyridone agent. The purpose of this study is to investigate the inhibitory effects of AKF‐PD… 
2012
2012
Cardiac myofibroblast differentiation, characterized by expression of alpha-smooth muscle actin (alpha-SMA) and fibrillar… 
2011
2011
Background/Aims: Fluorofenidone [1-(3-fluorophenyl)-5-methyl-2-(1H)-pyridone, AKF-PD], a novel pyridone agent, showed potent… 
2011
2011
Fluorofenidone (FD) is a novel pyridone agent with significant antifibrotic effects in vitro. The purpose of this study is to… 
2009
2009
Aim:  Fluorofenidone (1‐(3‐fluorophenyl)‐5‐methyl‐2‐(1H)‐pyridone) is a novel pyridone agent. The aim of the present study is to… 
2009
2009
OBJECTIVES The development of novel antifibrotic agent candidates for the treatment of diabetic nephropathy. The present study…